Buy and hold, hopefully forever…
There was much popping of corks and clinking of glasses in the City last week when the FTSE–finally–managed to surpass its previous closing peak of 6930, which was remarkably set on the last of 1999. Peaks being surpassed and earnings records being beaten should of course be something that happens with smooth regularity as economies advance […]
I have a soft spot for GSK; it was the first serious investment I made after I set up my ISA. It seemed to offer everything I was looking for: relatively cheap starting valuation, steady, predictable growth, a juicy dividend (paid quarterly, which is even better), global operations, and long track record of shareholder friendliness. We are […]
The idea of evaluating a share on the basis of whether it pays 2% or 2.5%, how well covered its payout is, and whether the payout ratio is rising or falling is repugnant to many investors. To these thrill seekers, the prospects for turbo-charged growth in earnings, blue skies thinking in the business model (for example […]